GLSHQ (Gelesis Holdings) LT-Debt-to-Total-Asset: 0.29 (As of Jun. 2023)


What is Gelesis Holdings LT-Debt-to-Total-Asset?

Gelesis Holdings GLSHQ -99.00% LT-Debt-to-Total-Asset is 0.29 as of Jun. 2023.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Gelesis Holdings's long-term debt to total assests ratio for the quarter that ended in Jun. 2023 was 0.29.

Gelesis Holdings's long-term debt to total assets ratio increased from Jun. 2022 (0.23) to Jun. 2023 (0.29). It may suggest that Gelesis Holdings is progressively becoming more dependent on debt to grow their business.

Gelesis Holdings  (OTCPK:GLSHQ) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Gelesis Holdings LT-Debt-to-Total-Asset Related Terms

Gelesis Holdings LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Gelesis Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelesis Holdings LT-Debt-to-Total-Asset Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
LT-Debt-to-Total-Asset
0.25 0.26

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.21 0.26 0.27 0.29

Gelesis Holdings LT-Debt-to-Total-Asset Calculation

Gelesis Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

LT Debt to Total Assets (A: Dec. 2022 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2022 )/Total Assets (A: Dec. 2022 )
=26.309/103.324
=0.25

Gelesis Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

LT Debt to Total Assets (Q: Jun. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Jun. 2023 )/Total Assets (Q: Jun. 2023 )
=27.963/95.875
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.29 mean?
Gelesis Holdings (GLSHQ) has a LT-Debt-to-Total-Asset of 0.29 as of Jun. 2023. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Gelesis Holdings and its competitors.
Is Gelesis Holdings' LT-Debt-to-Total-Asset too high?
Gelesis Holdings' current LT-Debt-to-Total-Asset is 0.29.
How does Gelesis Holdings' LT-Debt-to-Total-Asset compare to RBSH and PPCB?
Gelesis Holdings' LT-Debt-to-Total-Asset of 0.29 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Gelesis Holdings and its competitors. Gelesis Holdings's current LT-Debt-to-Total-Asset is 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelesis Holdings stock overvalued right now?
Gelesis Holdings (GLSHQ) has a current LT-Debt-to-Total-Asset of 0.29. The current LT-Debt-to-Total-Asset is 0.29. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Gelesis Holdings (GLSHQ), the current LT-Debt-to-Total-Asset is 0.29 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelesis Holdings Business Description

Address 501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.